Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
The global Paclitaxel market is projected to grow from US$ 128.1 million in 2024 to US$ 205.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.
North America and China are the largest producer of Paclitaxel, with a market share about 35% separately. Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.
Report Covers:
This report presents an overview of global market for Paclitaxel, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Paclitaxel, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Paclitaxel, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Paclitaxel sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Paclitaxel market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Paclitaxel sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Segment by Type
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Segment by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Paclitaxel in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Paclitaxel manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Paclitaxel sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Paclitaxel Product Introduction
1.2 Market by Type
1.2.1 Global Paclitaxel Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Natural Paclitaxel API
1.2.3 Semi-synthetic Paclitaxel API
1.3 Market by Application
1.3.1 Global Paclitaxel Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Ovarian Cancer
1.3.3 Cervical Cancer
1.3.4 Breast Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Paclitaxel Sales Estimates and Forecasts 2019-2030
2.2 Global Paclitaxel Revenue by Region
2.2.1 Global Paclitaxel Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Paclitaxel Revenue by Region (2019-2024)
2.2.3 Global Paclitaxel Revenue by Region (2025-2030)
2.2.4 Global Paclitaxel Revenue Market Share by Region (2019-2030)
2.3 Global Paclitaxel Sales Estimates and Forecasts 2019-2030
2.4 Global Paclitaxel Sales by Region
2.4.1 Global Paclitaxel Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Paclitaxel Sales by Region (2019-2024)
2.4.3 Global Paclitaxel Sales by Region (2025-2030)
2.4.4 Global Paclitaxel Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Paclitaxel Sales by Manufacturers
3.1.1 Global Paclitaxel Sales by Manufacturers (2019-2024)
3.1.2 Global Paclitaxel Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Paclitaxel in 2023
3.2 Global Paclitaxel Revenue by Manufacturers
3.2.1 Global Paclitaxel Revenue by Manufacturers (2019-2024)
3.2.2 Global Paclitaxel Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Paclitaxel Revenue in 2023
3.3 Global Key Players of Paclitaxel, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Paclitaxel Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Paclitaxel Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Paclitaxel, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Paclitaxel, Product Offered and Application
3.8 Global Key Manufacturers of Paclitaxel, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Paclitaxel Sales by Type
4.1.1 Global Paclitaxel Historical Sales by Type (2019-2024)
4.1.2 Global Paclitaxel Forecasted Sales by Type (2025-2030)
4.1.3 Global Paclitaxel Sales Market Share by Type (2019-2030)
4.2 Global Paclitaxel Revenue by Type
4.2.1 Global Paclitaxel Historical Revenue by Type (2019-2024)
4.2.2 Global Paclitaxel Forecasted Revenue by Type (2025-2030)
4.2.3 Global Paclitaxel Revenue Market Share by Type (2019-2030)
4.3 Global Paclitaxel Price by Type
4.3.1 Global Paclitaxel Price by Type (2019-2024)
4.3.2 Global Paclitaxel Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Paclitaxel Sales by Application
5.1.1 Global Paclitaxel Historical Sales by Application (2019-2024)
5.1.2 Global Paclitaxel Forecasted Sales by Application (2025-2030)
5.1.3 Global Paclitaxel Sales Market Share by Application (2019-2030)
5.2 Global Paclitaxel Revenue by Application
5.2.1 Global Paclitaxel Historical Revenue by Application (2019-2024)
5.2.2 Global Paclitaxel Forecasted Revenue by Application (2025-2030)
5.2.3 Global Paclitaxel Revenue Market Share by Application (2019-2030)
5.3 Global Paclitaxel Price by Application
5.3.1 Global Paclitaxel Price by Application (2019-2024)
5.3.2 Global Paclitaxel Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Paclitaxel Market Size by Type
6.1.1 US & Canada Paclitaxel Sales by Type (2019-2030)
6.1.2 US & Canada Paclitaxel Revenue by Type (2019-2030)
6.2 US & Canada Paclitaxel Market Size by Application
6.2.1 US & Canada Paclitaxel Sales by Application (2019-2030)
6.2.2 US & Canada Paclitaxel Revenue by Application (2019-2030)
6.3 US & Canada Paclitaxel Market Size by Country
6.3.1 US & Canada Paclitaxel Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Paclitaxel Sales by Country (2019-2030)
6.3.3 US & Canada Paclitaxel Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Paclitaxel Market Size by Type
7.1.1 Europe Paclitaxel Sales by Type (2019-2030)
7.1.2 Europe Paclitaxel Revenue by Type (2019-2030)
7.2 Europe Paclitaxel Market Size by Application
7.2.1 Europe Paclitaxel Sales by Application (2019-2030)
7.2.2 Europe Paclitaxel Revenue by Application (2019-2030)
7.3 Europe Paclitaxel Market Size by Country
7.3.1 Europe Paclitaxel Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Paclitaxel Sales by Country (2019-2030)
7.3.3 Europe Paclitaxel Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Paclitaxel Market Size
8.1.1 China Paclitaxel Sales (2019-2030)
8.1.2 China Paclitaxel Revenue (2019-2030)
8.2 China Paclitaxel Market Size by Application
8.2.1 China Paclitaxel Sales by Application (2019-2030)
8.2.2 China Paclitaxel Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Paclitaxel Market Size by Type
9.1.1 Asia Paclitaxel Sales by Type (2019-2030)
9.1.2 Asia Paclitaxel Revenue by Type (2019-2030)
9.2 Asia Paclitaxel Market Size by Application
9.2.1 Asia Paclitaxel Sales by Application (2019-2030)
9.2.2 Asia Paclitaxel Revenue by Application (2019-2030)
9.3 Asia Paclitaxel Sales by Region
9.3.1 Asia Paclitaxel Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Paclitaxel Revenue by Region (2019-2030)
9.3.3 Asia Paclitaxel Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Paclitaxel Market Size by Type
10.1.1 Middle East, Africa and Latin America Paclitaxel Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Paclitaxel Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Paclitaxel Market Size by Application
10.2.1 Middle East, Africa and Latin America Paclitaxel Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Paclitaxel Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Paclitaxel Sales by Country
10.3.1 Middle East, Africa and Latin America Paclitaxel Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Paclitaxel Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Paclitaxel Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Phyton
11.1.1 Phyton Company Information
11.1.2 Phyton Overview
11.1.3 Phyton Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Phyton Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Phyton Recent Developments
11.2 ScinoPharm
11.2.1 ScinoPharm Company Information
11.2.2 ScinoPharm Overview
11.2.3 ScinoPharm Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 ScinoPharm Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 ScinoPharm Recent Developments
11.3 Novasep
11.3.1 Novasep Company Information
11.3.2 Novasep Overview
11.3.3 Novasep Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Novasep Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novasep Recent Developments
11.4 Samyang
11.4.1 Samyang Company Information
11.4.2 Samyang Overview
11.4.3 Samyang Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Samyang Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Samyang Recent Developments
11.5 Polymed
11.5.1 Polymed Company Information
11.5.2 Polymed Overview
11.5.3 Polymed Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Polymed Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Polymed Recent Developments
11.6 TAPI (Teva)
11.6.1 TAPI (Teva) Company Information
11.6.2 TAPI (Teva) Overview
11.6.3 TAPI (Teva) Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 TAPI (Teva) Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 TAPI (Teva) Recent Developments
11.7 Fresenius-kabi
11.7.1 Fresenius-kabi Company Information
11.7.2 Fresenius-kabi Overview
11.7.3 Fresenius-kabi Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Fresenius-kabi Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Fresenius-kabi Recent Developments
11.8 Huiang biopharma
11.8.1 Huiang biopharma Company Information
11.8.2 Huiang biopharma Overview
11.8.3 Huiang biopharma Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Huiang biopharma Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Huiang biopharma Recent Developments
11.9 Southpharma
11.9.1 Southpharma Company Information
11.9.2 Southpharma Overview
11.9.3 Southpharma Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Southpharma Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Southpharma Recent Developments
11.10 Yunnan Hande
11.10.1 Yunnan Hande Company Information
11.10.2 Yunnan Hande Overview
11.10.3 Yunnan Hande Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Yunnan Hande Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Yunnan Hande Recent Developments
11.11 Hainan Yew Pharm
11.11.1 Hainan Yew Pharm Company Information
11.11.2 Hainan Yew Pharm Overview
11.11.3 Hainan Yew Pharm Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Hainan Yew Pharm Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hainan Yew Pharm Recent Developments
11.12 Jiangsu Yew Biotechnology
11.12.1 Jiangsu Yew Biotechnology Company Information
11.12.2 Jiangsu Yew Biotechnology Overview
11.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Jiangsu Yew Biotechnology Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Jiangsu Yew Biotechnology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Paclitaxel Industry Chain Analysis
12.2 Paclitaxel Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Paclitaxel Production Mode & Process
12.4 Paclitaxel Sales and Marketing
12.4.1 Paclitaxel Sales Channels
12.4.2 Paclitaxel Distributors
12.5 Paclitaxel Customers
13 Market Dynamics
13.1 Paclitaxel Industry Trends
13.2 Paclitaxel Market Drivers
13.3 Paclitaxel Market Challenges
13.4 Paclitaxel Market Restraints
14 Key Findings in The Global Paclitaxel Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
听
听
*If Applicable.